Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Clin Orthop Relat Res. 2018 Mar;476(3):548-555. doi: 10.1007/s11999.0000000000000055.
Preservation of limb function after resection of malignant bone tumors in skeletally immature children is challenging. Resection of bone sarcomas and reconstruction with an allograft in patients younger than 10 years old is one reconstructive alternative. However, long-term studies analyzing late complications and limb length discrepancy at skeletal maturity are scarce; this information would be important, because growth potential is altered in these patients owing to the loss of one physis during tumor resection.
QUESTIONS/PURPOSES: At a minimum followup of 10 years after reconstructions in children younger than 10 years of age at the time of reconstruction, we asked what is (1) the limb length discrepancy at skeletal maturity and how was it managed; (2) the risk of amputation; (3) the risk of allograft removal; and (4) the risk of second surgery resulting from complications?
Between 1994 and 2006, we performed 22 bone allografts after bone sarcoma resections in children younger than 10 years of age. Of those, none were lost to followup before the minimum followup of 10 years was reached, and an additional six had died of disease (of whom three died since our last report on this group of patients), leaving 16 patients whom we studied here. Followup on these patients was at a mean of 13.5 years (range, 10-22 years). During the period in question, no other treatments (such as extendible prostheses, amputations, etc) were used. The mean age at the time of the original surgery was 7 years (range, 2-10 years), and the mean age of the 16 alive patients at last followup was 20 years (range, 15-28 years). This series included 10 boys and six girls with 14 osteosarcomas and two Ewing sarcomas. Ten reconstructions were performed with an intercalary allograft and six with an osteoarticular allograft. The growth plate was uninvolved in three patients, whereas in the remaining 13, the growth plate was included in the resection (seven intercalary and six osteoarticular allografts). Limb length discrepancy at skeletal maturity was measured with full-length standing radiographs, and data were collected by retrospective study of a longitudinally maintained institutional database. The risk of amputation, allograft removal, and secondary surgery resulting from a complication was calculated by a competing-risk analysis method.
We observed no limb length discrepancy at skeletal maturity in the three patients with intercalary resections in whom we preserved the physes on both sides of the joint (two femurs and one tibia); however, one patient developed malalignment that was treated with corrective osteotomy of the tibia. The remaining 13 patients developed limb length discrepancy as a result of loss of one physis. Seven patients (four femurs, two tibias, and one humerus) developed shortening of ≤ 3 cm (mean, 2.4 cm; range, 1-3 cm) and no lengthening was performed. Six patients developed > 3 cm of limb discrepancy at skeletal maturity (all distal femoral reconstructions). In four patients this was treated with femoral lengthening, whereas two declined this procedure (each with 6 cm of shortening). In the four patients who had a lengthening procedure, one patient had a final discrepancy of 4 cm, whereas the other three had equal limb lengths at followup. The risk of amputation was 4% (95% confidence interval [CI], 0-15) and none occurred since our previous report. The risk of allograft removal was 15% (95% CI, 1-29) and none occurred since our previous report on this group of patients. The risk of other operations resulting from a complication was 38% (95% CI, 19-57). Eleven patients underwent a second operation resulting from a complication (three local recurrences, five fractures, one infection, one nonunion, and one tibial deformity), of which three were performed since our last report on this group of patients.
Limb length inequalities and subsequent procedures to correct them were common in this small series of very young patients as were complications resulting in operative procedures, but overall most allografts remained in place at long-term followup. In skeletally immature children, bone allograft is one alternative among several that are available (such as rotationplasty and endoprosthesis), and future studies with long followup may be able to compare the available options with one another.
Level IV, therapeutic study.
在骨骼未成熟的儿童中,切除恶性骨肿瘤后保留肢体功能是具有挑战性的。在 10 岁以下的患者中,切除骨肉瘤并用同种异体骨重建是一种重建选择。然而,目前缺乏分析长期并发症和骨骼成熟时肢体长度差异的研究;这些信息很重要,因为由于肿瘤切除时失去一个骺板,这些患者的生长潜力发生了改变。
问题/目的:在重建后至少 10 年的随访中,我们在重建时年龄小于 10 岁的儿童中询问以下内容:(1) 骨骼成熟时的肢体长度差异是多少,如何管理;(2) 截肢风险;(3) 同种异体移植物移除风险;(4) 并发症导致的二次手术风险?
1994 年至 2006 年期间,我们对 10 岁以下的儿童进行了 22 例骨肉瘤切除后同种异体骨移植。在这些患者中,没有一名患者在随访至少 10 年之前失访,另外 6 名患者因疾病死亡(其中 3 名在我们上次报告该组患者后死亡),剩下 16 名患者在此研究中。这些患者的随访时间平均为 13.5 年(范围,10-22 年)。在此期间,没有使用其他治疗方法(如可延长假体、截肢等)。原始手术时的平均年龄为 7 岁(范围,2-10 岁),最后一次随访时 16 名存活患者的平均年龄为 20 岁(范围,15-28 岁)。该系列包括 10 名男孩和 6 名女孩,14 例骨肉瘤和 2 例尤文肉瘤。10 例重建采用节段同种异体骨移植,6 例采用骨-关节同种异体骨移植。3 名患者的生长板未受累,而其余 13 名患者的生长板包含在切除范围内(7 例节段同种异体骨移植和 6 例骨-关节同种异体骨移植)。骨骼成熟时的肢体长度差异通过全长站立位 X 线片测量,并通过对纵向维护的机构数据库进行回顾性研究收集数据。通过竞争风险分析方法计算截肢、同种异体移植物移除和并发症导致的二次手术的风险。
在我们保留关节两侧骺板的 3 例节段切除患者中(2 例股骨和 1 例胫骨),没有观察到骨骼成熟时的肢体长度差异;然而,1 例患者出现了对线不良,通过胫骨矫正截骨术进行了治疗。其余 13 名患者由于失去一个骺板而出现肢体长度差异。7 名患者(4 例股骨、2 例胫骨和 1 例肱骨)出现≤3cm 的缩短(平均 2.4cm;范围,1-3cm),未进行延长。6 名患者在骨骼成熟时出现>3cm 的肢体差异(均为股骨远端重建)。在 4 名患者中,通过股骨延长术进行了治疗,而另外 2 名患者拒绝了该手术(各有 6cm 的缩短)。在进行延长手术的 4 名患者中,1 名患者最终差异为 4cm,而其余 3 名患者在随访时肢体长度相等。截肢风险为 4%(95%置信区间[CI],0-15),自上次报告以来,没有发生。同种异体移植物移除的风险为 15%(95%CI,1-29),自上次报告以来,没有发生。并发症导致的其他手术风险为 38%(95%CI,19-57)。11 名患者因并发症行二次手术(3 例局部复发、5 例骨折、1 例感染、1 例骨不连和 1 例胫骨畸形),其中 3 例自上次报告该组患者以来进行了手术。
在这个非常年轻的患者小系列中,肢体长度不相等以及随后的矫正手术、并发症导致的手术都很常见,但总的来说,大多数同种异体移植物在长期随访中仍然存在。在骨骼未成熟的儿童中,同种异体骨是可选择的几种方法之一(如旋转成形术和假体),未来的长期随访研究可能能够比较这些可选择的方法。
IV 级,治疗研究。